TGFBR1 and Alzheimer disease: Similarly, analysis of the GSE15222 dataset (177 AD patients and 187 controls) revealed a 17% transcriptional down‐regulation of cortical Tgf‐βr1 expression in AD patients compared to healthy individuals (Figure S15B, Supporting Information).